Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy - PubMed
- ️Tue Jan 01 2019
Review
. 2019 Dec 1;21(6):497-517.
doi: 10.1684/epd.2019.1105.
Affiliations
- PMID: 31782407
- DOI: 10.1684/epd.2019.1105
Review
Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy
Torbjörn Tomson et al. Epileptic Disord. 2019.
Abstract
The risks associated with use of antiepileptic drugs during pregnancy are a major concern for all women with epilepsy with childbearing potential. These risks have to be balanced against foetal and maternal risks associated with uncontrolled seizures. This report from the International League Against Epilepsy Task Force on Women and Pregnancy aims to provide a summary of relevant data on these risks as a basis for expert opinion recommendations for the management of epilepsy in pregnancy. The report reviews data on maternal and foetal risks associated with seizures as well as teratogenic risks associated with antiepileptic drug exposure, including effects on intrauterine growth, major congenital malformations, and developmental and behavioural outcomes. The impact of pregnancy on seizure control and on the pharmacokinetics of antiepileptic drugs are also discussed. This information is used to discuss how treatment may be optimized before conception and further managed during pregnancy.
Keywords: antiepileptic drugs; epilepsy; foetal risks; pregnancy; teratogenesis.
Similar articles
-
Teratogenic effects of antiepileptic drugs.
Tomson T, Battino D. Tomson T, et al. Lancet Neurol. 2012 Sep;11(9):803-13. doi: 10.1016/S1474-4422(12)70103-5. Epub 2012 Jul 16. Lancet Neurol. 2012. PMID: 22805351 Review.
-
Foetal safety of old and new antiepileptic drugs.
Verrotti A, Mencaroni E, Castagnino M, Zaccara G. Verrotti A, et al. Expert Opin Drug Saf. 2015 Oct;14(10):1563-71. doi: 10.1517/14740338.2015.1084288. Epub 2015 Sep 2. Expert Opin Drug Saf. 2015. PMID: 26329145 Review.
-
Antiepileptic treatment in pregnant women: morphological and behavioural effects.
Tomson T, Battino D. Tomson T, et al. Handb Exp Pharmacol. 2011;205:295-315. doi: 10.1007/978-3-642-20195-0_15. Handb Exp Pharmacol. 2011. PMID: 21882118
-
Epilepsy, pregnancy, and the child.
Kaneko S. Kaneko S. Epilepsia. 2000;41 Suppl 9:8-13. doi: 10.1111/j.1528-1157.2000.tb02211.x. Epilepsia. 2000. PMID: 11156513
-
Lindhout D, Omtzigt JG. Lindhout D, et al. Epilepsia. 1994;35 Suppl 4:S19-28. doi: 10.1111/j.1528-1157.1994.tb05952.x. Epilepsia. 1994. PMID: 8174516 Review.
Cited by
-
Daugaard CA, Pedersen L, Sun Y, Dreier JW, Christensen J. Daugaard CA, et al. JAMA Netw Open. 2020 Nov 2;3(11):e2025570. doi: 10.1001/jamanetworkopen.2020.25570. JAMA Netw Open. 2020. PMID: 33170264 Free PMC article.
-
Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.
Pennell PB, French JA, May RC, Gerard E, Kalayjian L, Penovich P, Gedzelman E, Cavitt J, Hwang S, Pack AM, Sam M, Miller JW, Wilson SH, Brown C, Birnbaum AK, Meador KJ; MONEAD Study Group. Pennell PB, et al. N Engl J Med. 2020 Dec 24;383(26):2547-2556. doi: 10.1056/NEJMoa2008663. N Engl J Med. 2020. PMID: 33369356 Free PMC article.
-
Terman SW, Kirkpatrick L, Kerr WT, Akiyama LF, Baajour W, Atilgan D, Dorotan MKC, Choi HW, French JA. Terman SW, et al. Epilepsia. 2024 Apr;65(4):846-860. doi: 10.1111/epi.17875. Epub 2024 Jan 5. Epilepsia. 2024. PMID: 38135921 Review.
-
Tatebayashi K, Takumi I, Matsumori T, Kawaguchi K, Murata H. Tatebayashi K, et al. NMC Case Rep J. 2023 Nov 11;10:321-325. doi: 10.2176/jns-nmc.2023-0083. eCollection 2023. NMC Case Rep J. 2023. PMID: 38076393 Free PMC article.
-
Issues of Women with Epilepsy and Suitable Antiseizure Drugs.
Lee SK. Lee SK. J Epilepsy Res. 2023 Dec 31;13(2):23-35. doi: 10.14581/jer.23005. eCollection 2023 Dec. J Epilepsy Res. 2023. PMID: 38223363 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical